Nicole Sherry

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet · 2011 · 489 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study

Torunn I. Yock, Beow Y. Yeap, David H. Ebb et al. · The Lancet Oncology · 2016 · 338 citations

Medicine, Oncology, Radiation Oncology +17

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Mark Rigby, Kristina M. Harris, Ashley Pinckney et al. · Journal of Clinical Investigation · 2015 · 292 citations · Full text

Medicine, Endocrinology, Immunology +17

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes

William Hagopian, Robert J. Ferry, Nicole Sherry et al. · Diabetes · 2013 · 241 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +14

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

Mark Rigby, Linda A. DiMeglio, Marc Rendell et al. · The Lancet Diabetes & Endocrinology · 2013 · 206 citations · Full text

Life Sciences, Endocrinology, Immunology +17